
|Expert Interviews|April 18, 2022
Expert Interview: Pfizer/BioNTech Immune Response in Pediatric Clinical Trials
Author(s)Lois Levine, MA
Pfizer/BioNTech announce positive results for a third dose of their COVID-19 vaccine for children.
Advertisement
Grant Paulsen, MD, assistant professor, Division of Infectious Disease, Department of Pediatrics, Cincinnati Children's Hospital Medical Center in Ohio, and primary investigator for the hospital's clinical trial for a third dose (booster) for the Pfizer/BioNTech vaccine for COVID-19, discusses what the data might mean for children aged 5 to 11 years.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Hidden in Plain Sight: Legal Substances Putting Children at Risk
2
Trump Administration Lays Out Great Healthcare Plan for Lower Patient Costs
3
Fremanezumab Reduces Monthly Migraine Days for Pediatric Patients
4
Gestational Diabetes Increases Risk of Worse Postpartum Cardiovascular Health
5










































































































































































































